Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Retina, Basic & Translational Research, Neuro-ophthalmology

Trust Your Gut

When asked to think of an ecosystem with over 1,000 different species, a tropical rainforest or a coral reef might spring to mind. A few of you may immediately think of the biological party platter that resides in your gut, which acts as a cozy home to trillions of microbes that keep us ticking over. Many people – and some doctors – would be forgiven for thinking that, because these microbes inhabit our intestines, their only impact is on gastrointestinal health. However, our gut microbiome is also crucial to the health of other organs of the body – including the eyes! This interaction, in which a balance exists between gut wildlife and healthy function and disease in the eyes, is called the gut-eye axis. A shift in the contents or health of the gut microbiome can throw off this balance, inducing or exacerbating ophthalmic diseases such as uveitis, AMD, diabetic retinopathy, or retinitis pigmentosa (RP).

A research team from Spain’s University of Alicante have found that, in mice, retinal degeneration in RP is associated with specific changes in the gut microbiome (1). In particular, four common microbe genera – Rikenella, Muribaculaceace, Prevotellaceae UCG-001, and Bacilli – are missing in mice with retinal disease, whereas Bacteroides caecimuris is heavily enriched. This indicates that measuring shifts in microbiome composition could offer a simple biomarker of RP and other retinal diseases, as well as suggesting the gut-eye axis as a potential therapeutic target.

This research adds to previous evidence that the gut microbiome is important in a wide variety of disease states and warrants further research into the balance of the gut-eye axis.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. O Kutsyr et al., Sci Rep, 11, 6692 (2021). PMID: 33758301.
About the Author
Geoffrey Potjewyd

Associate Editor, The Ophthalmologist

The lion’s share of my PhD was spent in the lab, and though I mostly enjoyed it (mostly), what I particularly liked was the opportunity to learn about the latest breakthroughs in research. Communicating science to a wider audience allows me to scratch that itch without working all week only to find my stem cell culture has given up the ghost on the Friday (I’m not bitter). Fortunately for me, it turns out writing is actually fun – so by working for Texere I get to do it every day, whilst still being an active member of the clinical and research community.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register